Continuing review of an approved and ongoing protocol
Must be conducted by a convened IRB.
Is limited to review of unanticipated problems.
Must occur within 12 months of the approval date.
Is not required unless additional risks have been identified.
Answer: Must occur within 12 months of the approval date.
If the answers is incorrect or not given, you can answer the above question in the comment box. If the answers is incorrect or not given, you can answer the above question in the comment box.